
Am J Psychiatry 163:1905-1917, November 2006
doi: 10.1176/appi.ajp.163.11.1905
© 2006 American Psychiatric Association
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
A. John Rush, M.D.,
Madhukar H. Trivedi, M.D.,
Stephen R. Wisniewski, Ph.D.,
Andrew A. Nierenberg, M.D.,
Jonathan W. Stewart, M.D.,
Diane Warden, Ph.D., M.B.A.,
George Niederehe, Ph.D.,
Michael E. Thase, M.D.,
Philip W. Lavori, Ph.D.,
Barry D. Lebowitz, Ph.D.,
Patrick J. McGrath, M.D.,
Jerrold F. Rosenbaum, M.D.,
Harold A. Sackeim, Ph.D.,
David J. Kupfer, M.D.,
James Luther, M.A., and
Maurizio Fava, M.D.
OBJECTIVE: This report describes the participants and compares the acute and longer-term treatment outcomes associated with each of four successive steps in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial. METHOD: A broadly representative adult outpatient sample with nonpsychotic major depressive disorder received one (N=3,671) to four (N=123) successive acute treatment steps. Those not achieving remission with or unable to tolerate a treatment step were encouraged to move to the next step. Those with an acceptable benefit, preferably symptom remission, from any particular step could enter a 12-month naturalistic follow-up phase. A score of 5 on the Quick Inventory of Depressive SymptomatologySelf-Report (QIDS-SR16) (equivalent to 7 on the 17-item Hamilton Rating Scale for Depression [HRSD17]) defined remission; a QIDS-SR16 total score of 11 (HRSD17 14) defined relapse. RESULTS: The QIDS-SR16 remission rates were 36.8%, 30.6%, 13.7%, and 13.0% for the first, second, third, and fourth acute treatment steps, respectively. The overall cumulative remission rate was 67%. Overall, those who required more treatment steps had higher relapse rates during the naturalistic follow-up phase. In addition, lower relapse rates were found among participants who were in remission at follow-up entry than for those who were not after the first three treatment steps. CONCLUSIONS: When more treatment steps are required, lower acute remission rates (especially in the third and fourth treatment steps) and higher relapse rates during the follow-up phase are to be expected. Studies to identify the best multistep treatment sequences for individual patients and the development of more broadly effective treatments are needed.
Related Article:
-
In This Issue
Am J Psychiatry 2006 163: A66.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
S. C. Yudofsky
Changing Tides in Neurosurgical Interventions for Treatment-Resistant Depression
Am J Psychiatry,
June 1, 2008;
165(6):
671 - 674.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al.
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
J Psychopharmacol,
June 1, 2008;
22(4):
343 - 396.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. I. Scott and T. Fraser
Decreased usage of electroconvulsive therapy: implications
The British Journal of Psychiatry,
June 1, 2008;
192(6):
476 - 476.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shuchman MD and P. C. Hebert MD MHSc
Bringing a research base to psychiatry
Can. Med. Assoc. J.,
May 6, 2008;
178(10):
1257 - 1258.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shuchman MD and P. C. Hebert MD MHSc
Etablir une base de recherche en psychiatrie
Can. Med. Assoc. J.,
May 6, 2008;
178(10):
1259 - 1260.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Rush MD
Developing the evidence for evidence-based practice
Can. Med. Assoc. J.,
May 6, 2008;
178(10):
1313 - 1315.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Rohde, S. G. Silva, S. T. Tonev, B. D. Kennard, B. Vitiello, C. J. Kratochvil, M. A. Reinecke, J. F. Curry, A. D. Simons, and J. S. March
Achievement and Maintenance of Sustained Response During the Treatment for Adolescents With Depression Study Continuation and Maintenance Therapy
Arch Gen Psychiatry,
April 1, 2008;
65(4):
447 - 455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Brent, G. Emslie, G. Clarke, K. D. Wagner, J. R. Asarnow, M. Keller, B. Vitiello, L. Ritz, S. Iyengar, K. Abebe, et al.
Switching to Another SSRI or to Venlafaxine With or Without Cognitive Behavioral Therapy for Adolescents With SSRI-Resistant Depression: The TORDIA Randomized Controlled Trial
JAMA,
February 27, 2008;
299(8):
901 - 913.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Timonen and T. Liukkonen
Management of depression in adults
BMJ,
February 23, 2008;
336(7641):
435 - 439.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. H. Levine and R. C. Albucher
Patient Management Exercise: Major Depressive Disorder and Suicide
Focus,
January 1, 2008;
6(1):
47 - 57.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Bibliography for Major Depressive Disorder and Suicide
Focus,
January 1, 2008;
6(1):
58 - 62.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. I. KEITNER, D. A. SOLOMON, and C. E. RYAN
STAR*D: Have We Learned the Right Lessons?
Am J Psychiatry,
January 1, 2008;
165(1):
133 - 133.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Thase, E. S. Friedman, M. M. Biggs, S. R. Wisniewski, M. H. Trivedi, J. F. Luther, M. Fava, A. A. Nierenberg, P. J. McGrath, D. Warden, et al.
Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report
Focus,
January 1, 2008;
6(1):
104 - 119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. RUSH
Dr. Rush Replies
Am J Psychiatry,
January 1, 2008;
165(1):
133 - 134.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Thase
Molecules That Mediate Mood
N. Engl. J. Med.,
December 6, 2007;
357(23):
2400 - 2402.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Lisanby
Electroconvulsive Therapy for Depression
N. Engl. J. Med.,
November 8, 2007;
357(19):
1939 - 1945.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Badaracco
Keeping Our Depressed Patients in the Right Treatment Long Enough for Them to Get Better: Some Hopeful Findings
Am J Psychiatry,
August 1, 2007;
164(8):
1136 - 1139.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. T. Brady
Medical Treatment of Opiate Dependence: Expanding Treatment Options
Am J Psychiatry,
May 1, 2007;
164(5):
702 - 704.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Thase, E. S. Friedman, M. M. Biggs, S. R. Wisniewski, M. H. Trivedi, J. F. Luther, M. Fava, A. A. Nierenberg, P. J. McGrath, D. Warden, et al.
Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report
Am J Psychiatry,
May 1, 2007;
164(5):
739 - 752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Bridge, S. Iyengar, C. B. Salary, R. P. Barbe, B. Birmaher, H. A. Pincus, L. Ren, and D. A. Brent
Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant Treatment: A Meta-analysis of Randomized Controlled Trials
JAMA,
April 18, 2007;
297(15):
1683 - 1696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Rush
STAR*D: What Have We Learned?
Am J Psychiatry,
February 1, 2007;
164(2):
201 - 204.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Koran M.D.
Obsessive-Compulsive Disorder: An Update for the Clinician
Focus,
January 1, 2007;
5(3):
299 - 313.
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2006
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|